Navigation Links
Genzyme Reports Strong First-Quarter Growth
Date:4/23/2008

ty method

investments 188 5,612

Minority interest 463 3,912

Gain (loss) on investments in

equity securities (3) 775 12,788

Other (160) (525)

Investment income 14,870 16,219

Interest expense (1,655) (4,188)

Total other income (expenses) 14,481 33,818

Income (loss) before income taxes (1) 205,388 229,380

(Provision for) benefit from income

taxes (1) (60,117) (71,193)

Net income (loss) (1) $145,271 $158,187

Net income (loss) per share:

Basic $0.54 $0.60

Diluted (1,4) $0.52 $0.57

Weighted average shares outstanding:

Basic 267,276 263,476

Diluted (1,4) 285,208 279,924

(1) In accordance with the provisions of Financial Accounting Standards

Board, or FASB, Statement of Financial Accounting Standards No., or

FAS, 123R, "Share-Based Payment, an amendment of FASB Statement Nos.

123 and 95," we recorded pre-tax charges for stock-based compensation

expense and related tax benefits of:

Three Months Ended

March 31,

2008 2007

Cost of products and services sold $(6,514) $(5,896)

Selling, general and administrative


'/>"/>
SOURCE Genzyme Corp.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19

Related biology technology :

1. Genzyme to Build New R&D Center in Beijing
2. Genzyme Provides Update on Myozyme(R) Manufacturing
3. Genzyme Withdraws Bioenvisions European Filing of Evoltra(R) in Elderly AML Patients
4. Genzyme Launches Renvela(R) in the U.S. for Dialysis Patients
5. Genzyme and Isis Announce Hart-Scott-Rodino Approval of Collaboration
6. Genzyme and Isis Announce Strategic Alliance Including Exclusive Worldwide License of Mipomersen
7. BioMarin and Genzyme Restructure Aldurazyme 50/50 Joint Venture
8. Genzyme Receives European CE Mark for Single-Treatment Synvisc-One(TM)
9. Genzyme Announces FDA Approval of Thyrogen(R) for Use in Thyroid Cancer Ablation
10. Genzyme Study of Myozyme(R) for Late-Onset Pompe Patients Meets Co-Primary Efficacy Endpoints
11. Genzyme and Sunway to Collaborate on Gene Therapy Program in China
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)... (PRWEB) July 30, 2014 Vycom announces ... of products, designed to meet Factory Mutual (FM) 4910 ... materials such as wet benches, process tools, fume hoods, ... safety and damage to semiconductor wafers used in electronic ... a flame-retardant PVC solution with excellent workability and superior ...
(Date:7/30/2014)... SAN DIEGO , July 30, 2014   ... that designs and develops novel diagnostics to personalize and ... the appoint of Gregory T. Lucier as ... previously chairman and CEO of Life Technologies (formerly Invitrogen). ... expertise as Epic commercializes its circulating rare cell analysis ...
(Date:7/30/2014)... CA (PRWEB) July 30, 2014 ... from the U.S. Environmental Protection Agency (EPA). This ... in developmental toxicity models, including tests designed to ... formation and the formation of connections between neurons ... of neurodifferentiation and synapse formation by environmental pollutants ...
(Date:7/29/2014)... “PharmaSphere: Emerging Biotech Investment Report ... Funding” report provides in-depth analysis of the current ... venture capital segments of the financial industry, bearing ... significant impact on the future of emerging biotechnology ... report identifies regions of the world that are ...
Breaking Biology Technology:Vycom Announces Flametec® Thermax PVC (FM4910 Listed) For a Variety of Clean Room Applications with Excellent Workability and Aesthetics 2Epic Sciences Appoints Greg Lucier as Chairman of the Board of Directors 2Epic Sciences Appoints Greg Lucier as Chairman of the Board of Directors 3U.S. Environmental Protection Agency (EPA) Awards Vala Sciences a Second ToxCast Contract 2U.S. Environmental Protection Agency (EPA) Awards Vala Sciences a Second ToxCast Contract 3Strategic Trends of Biotech Investment Industry (Private Equity and Venture Capital Funding) in New Report Available at MarketOptimizer.org 2Strategic Trends of Biotech Investment Industry (Private Equity and Venture Capital Funding) in New Report Available at MarketOptimizer.org 3Strategic Trends of Biotech Investment Industry (Private Equity and Venture Capital Funding) in New Report Available at MarketOptimizer.org 4
... China , July 6 /PRNewswire-Asia-FirstCall/ -- Dehaier Medical,Systems Ltd. (Nasdaq: ... devices and homecare medical products in China ,today reaffirmed the company,s earlier ... , , ... , , , ...
... NEW YORK , July 6 /PRNewswire-Asia-FirstCall/ -- NeoStem, Inc. ... operations in the U.S. and China , today announced that it ... New,Economy,s Biotech Awards, which identify excellence in the field of technology. , ... According ...
... BEIJING , July 2 /PRNewswire-Asia-FirstCall/ -- ... the "Company") a leading manufacturer, developer,and distributor of ... China , today announced that the Company has ... plant nutrient production line from 10,000,tons to 15,000 ...
Cached Biology Technology:Dehaier Medical Systems Reaffirms Earnings Estimate of $0.80 EPS for FY 2010 2Dehaier Medical Systems Reaffirms Earnings Estimate of $0.80 EPS for FY 2010 3Dehaier Medical Systems Reaffirms Earnings Estimate of $0.80 EPS for FY 2010 4NeoStem Named 'Best Stem Cell Company' in The New Economy's 2010 Biotech Awards 2NeoStem Named 'Best Stem Cell Company' in The New Economy's 2010 Biotech Awards 3NeoStem Named 'Best Stem Cell Company' in The New Economy's 2010 Biotech Awards 4Yongye International Expands Its Existing Production Capacity by 50% and Provides Updates on Customer List Acquisition 2Yongye International Expands Its Existing Production Capacity by 50% and Provides Updates on Customer List Acquisition 3Yongye International Expands Its Existing Production Capacity by 50% and Provides Updates on Customer List Acquisition 4
(Date:7/29/2014)... and applications for imaging and manipulation of the brain ... the inspiration behind Neurophotonics , a new peer-reviewed ... and photonics. , The first issue coincides with the ... and a special section features articles that lay out ... that optics and photonics will have on advancing our ...
(Date:7/29/2014)... world of science, researchers sometimes need to get ... did just that to study the impacts of ... coral reef ecosystems at two remote locations in ... animal tracking and computer simulation, McCauley, an assistant ... Marine Biology, and his colleagues sought to understand ...
(Date:7/29/2014)... -- Research and Markets  has announced the addition ... 2014-2018" report to their offering. ... BI refers to applications and technologies that are used ... a company,s operations. BI help organizations to acquire comprehensive ... metrics on sales, production, and internal operations. ...
Breaking Biology News(10 mins):SPIE launches Neurophotonics journal with special section on BRAIN Initiative 2SPIE launches Neurophotonics journal with special section on BRAIN Initiative 3Underwater elephants 2Underwater elephants 3Global SaaS-based Business Intelligence (BI) Market 2014-2018 2
... N.J. March 28, 2013 - Deborah E. Wiley, Chair of ... & JWb) will present the 2013 Wiley Prize in Biomedical ... Brandeis University (Emeritus), and Dr. Michael Rosbash, Brandeis University on ... Caspary Auditorium, The Rockefeller University, 1230 York Avenue, New York, ...
... can add up to a lot. In short, that,s ... streams and pollution by Steve Powers, a postdoctoral researcher ... (ECI). "Small dams, reservoirs and ponds trap water ... Powers said. "This is especially relevant in agricultural lands ...
... , March 28, 2013  Lockheed Martin [NYSE: ... aimed at expanding its collaboration with Silicon Valley ... the federal government. Called the ... will provide the federal government with greater visibility ...
Cached Biology News:2013 Wiley Prize to be awarded at Apr. 5 event 2Notre Dame researcher is studying role small dams play in pollution control 2Lockheed Martin Launches Technology Hub To Connect Silicon Valley Innovators With Federal Government Needs 2
Mouse monoclonal [4A2.2] to SLC6A4 ( Abpromise for all tested applications). entrezGeneID: 6532 SwissProtID: P31645...
... The 2/3D Waver Shaker combines shaking and rocking ... a 330 x 330 mm stainless steel or ... incubator and cold room operation. The platform angle ... for a vigorous with action and rotation speed ...
Anti-DNA Polymerase a, Human Description: 50 l Research Focus: cancer & cell proliferation Storage: 4C Shipping Temperature: 4C...
... for 25 chips provides the chips and ... (at picogram levels) with the Experion automated ... HighSens microfluidic chips, 2 x 1,250 microliters ... HighSens stain, 20 microliters RNA ladder, 2 ...
Biology Products: